USPTO serial 79342155
ACCIO BIOBANKONLINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 25, 2023
- Examiner
- FRUM MILONE, MARCIE R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ACCIO BIOBANKONLINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gabrielle A. Holley
Gabrielle A. Holley Holley & Menker, P.A.P.O. Box 96Solana Beach, CA 92075UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals used in industry and science; stem cells, except for those used for medical or veterinary purposes; stem cells for research purposes; stem cells for scientific purposes; preservatives for use in the pharmaceutical industry and the preservation of tissue for use in the pharmaceutical industry or for preservation and preparation of biopsy specimens for experimental research | ACTIVE | — |
| 004 | Formalin fixed paraffin embedded blocks used in clinical and research laboratories to create a formalin-fixed, paraffin-embedded (FFPE) block of tissue | ACTIVE | — |
| 005 | Pharmaceutical and veterinary pharmaceutical preparations for the treatment of or research of biological specimens; annotated human bio samples, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens derived from the division of one original specimen for use in scientific and medical research; human tissue and specimens, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens derived from the division of one original specimen for use in scientific and medical research; fresh human organs, tissues and biofluids, namely, fresh paraffin-embedded (FFPE) human biological specimens derived from the division of one original specimen for use in scientific and medical research; post mortem tissues and organs, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens derived from the division of one original specimen for use in scientific and medical research; frozen human tissues, namely, frozen human biological specimens derived from the division of one original specimen for use in scientific and medical research; blood for medical purposes; digestive system tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being digestive tissue derived from the division of one original specimen for use in scientific and medical research; nervous system tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being nervous system tissue derived from the division of one original specimen for use in scientific and medical research; respiratory system tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being respiratory systems tissue derived from the division of one original specimen for use in scientific and medical research; urinary tract tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being urinary tract tissue derived from the division of one original specimen for use in scientific and medical research; endocrine glands, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being endocrine glands derived from the division of one original specimen for use in scientific and medical research; cardiovascular tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being cardiovascular tissue derived from the division of one original specimen for use in scientific and medical research; lymphatic system tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being lymphatic system tissue derived from the division of one original specimen for use in scientific and medical research; sensory organs, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being sensory organs derived from the division of one original specimen for use in scientific and medical research; integumentary system tissue namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being integumentary system tissue derived from the division of one original specimen for use in scientific and medical research; musculoskeletal tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being musculoskeletal tissue derived from the division of one original specimen for use in scientific and medical research; female reproductive tract tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being female reproductive tract tissue derived from the division of one original specimen for use in scientific and medical research; male reproductive tract tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being male reproductive tract tissue derived from the division of one original specimen for use in scientific and medical research; pathologist-dissected and annotated tissue samples, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens derived from the division of one original specimen for use in scientific and medical research; veterinary tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) animal biological specimens derived from the division of one original specimen for use in scientific and medical research; blood samples for use in clinical and research laboratories; breast tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being breast tissue derived from the division of one original specimen for use in scientific and medical research; central nervous system tissues, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being central nervous system tissues derived from the division of one original specimen for use in scientific and medical research; brain or spine tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being brain or spine tissue derived from the division of one original specimen for use in scientific and medical research; heart and heart tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being heart or heart tissue derived from the division of one original specimen for use in scientific and medical research; blood vessels for use in clinical and research laboratories; endocrine tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being endocrine tissue derived from the division of one original specimen for use in scientific and medical research; gastrointestinal tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being gastrointestinal tissue derived from the division of one original specimen for use in scientific and medical research; genitourinary tissue , namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being genitourinary tissue derived from the division of one original specimen for use in scientific and medical research; hematopoietic tissue namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being hematopoietic tissue derived from the division of one original specimen for use in scientific and medical research; bone marrow being bone morphogenetic protein for use in clinical and research laboratories; mesothelial cells, namely, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being mesothelial cells derived from the division of one original specimen for use in scientific and medical research; respiratory tissue, namely, fresh, frozen, or formalin-fixed, paraffin-embedded (FFPE) human biological specimens being respiratory tissue derived from the division of one original specimen for use in scientific and medical research; skin being biological skin tissue for use in clinical and research laboratories; subcutaneous fat being biological skin tissue for use in clinical and research laboratories; colostral antibodies for use in clinical and research laboratories; stem cells for medical use; biological preparations being biological tissue cultures for medical purposes; biological tissue cultures for medical purposes | ACTIVE | — |
| 010 | processed bone samples | ACTIVE | — |
| 039 | Storage and distribution of human tissues and cells for medical use or for use in clinical and research laboratories; packaging to the order and specification of others and warehousing of human tissues and cells for medical use or for use in clinical and research laboratories; Cryogenic storage of biological tissue, namely, the storage of human cells, organs or tissue for medical use or for use in clinical and research laboratories; arranging being providing the transport, storage and delivery of human or animal tissues and organs for medical use or for use in clinical and research laboratories | ACTIVE | — |
| 042 | Scientific research and development of all methods for preserving human tissue; pharmacological and biological scientific research services; DNA testing services being genetic testing for scientific research purposes; biological research; biomedical research services; medical or clinical laboratory services; provision of scientific laboratory facilities in the nature of medical or clinical laboratories; conducting clinical trials services for others; biotechnology research, biorepository research, and medical research support service in the nature of providing information about medical and scientific research ; medical research services; scientific research services relating to the isolation and cultivation of human tissues and cells; stem cell research; cell separation technology services in the nature of providing information about medical and scientific research; scientific research for the collection, analysis and storage of clinical samples and biospecimens; analysis of human tissues for medical research being scientific research; DNA screening for scientific research services being genetic testing for scientific research purposes; DNA sequencing for all fields of genomics, proteomics, metabolomics, biomedicine, biosciences and bioinformatics being genetic testing for scientific research purposes; computer software development and consulting services in the fields of genomics, proteomics, metabolomics, biomedicine, biosciences, biorepositories, biotechnology and bioinformatics; rental of science and technology equipment in the nature of rental of medical or clinical equipment; hosting of databases relating to tissue samples, organs, clinical bio sample data and donors being software as a service (SAAS) services, namely, hosting software for use by others for the provision of tissue samples, organs, clinical bio sample data and donor data; consultancy and information relating to the aforesaid provided online or on the Internet, namely, scientific research consulting in the field of the provision of tissue samples, organs, and clinical bio samples; preparation of biological samples for testing and analysis in research laboratories being biological research | ACTIVE | — |
| 044 | Human tissue and human cell bank services; blood, organ and tissue bank services; animal tissue bank services; genotyping being gene bank services; blood bank services; services for the medical testing of blood; DNA bank services; collection, testing, treatment and preservation of human tissues and cells being cultured cell bank services for medical transplantation; stem cell bank; sperm bank services; laboratory services in the treatment or examination of tissues being medical analysis services for diagnostic and treatment purposes provided by medical laboratories; collection and preservation of human blood; medical laboratory services for the analysis of samples taken from patients being medical analysis or labeling services for diagnostic and treatment purposes provided to medical laboratories; services for the storage, collection and analysis of clinical and laboratory tissue samples being research support services for facilitating diagnostic and treatment laboratory research for laboratories; post mortem tissue sample procurement services being tissue bank services; clinical tissue procurement services for research; advice, consultancy and information relating to the aforesaid services provided online or on the Internet being consulting services to clinical and research laboratories | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Tissue For Research Ltd
- Other trademarks owned by Tissue For Research Ltd
- Other trademarks owned by Tissue For Research Ltd
- Other trademarks in Class 001
- Other trademarks in Class 004
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ACCIO BIOBANKONLINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 28, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 4, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 4, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 25, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 25, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 25, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 7, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 18, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 31, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 28, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 27, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 27, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 29, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 29, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 29, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 28, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 10, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 9, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |